These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862 [TBL] [Abstract][Full Text] [Related]
5. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center. Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713 [TBL] [Abstract][Full Text] [Related]
7. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Regueiro M; Mardini H Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443 [TBL] [Abstract][Full Text] [Related]
8. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease. Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625 [TBL] [Abstract][Full Text] [Related]
9. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051 [TBL] [Abstract][Full Text] [Related]
12. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease. Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534 [TBL] [Abstract][Full Text] [Related]
13. Infliximab and surgical treatment of complex anal Crohn's disease. Duff S; Sagar PM; Rao M; Dolling S; Sprakes M; Hamlin PJ Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707 [TBL] [Abstract][Full Text] [Related]
14. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431 [TBL] [Abstract][Full Text] [Related]
15. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study. Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155 [TBL] [Abstract][Full Text] [Related]
16. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q; Hogezand RA; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330 [TBL] [Abstract][Full Text] [Related]
18. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Schwartz DA; White CM; Wise PE; Herline AJ Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987 [TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease]. Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study. Tonelli F; Giudici F; Asteria CR Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]